CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma

NCT00893516 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Portfolio consolidation.

Conditions

T-cell Lymphoma

Interventions

BIOLOGICAL: CHOP + CD4
DRUG: CHOP

Sponsor

Emergent BioSolutions